Richard Boehme

4.3k total citations · 1 hit paper
28 papers, 3.5k citations indexed

About

Richard Boehme is a scholar working on Epidemiology, Virology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Richard Boehme has authored 28 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 9 papers in Virology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Richard Boehme's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (6 papers) and Hepatitis C virus research (5 papers). Richard Boehme is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (6 papers) and Hepatitis C virus research (5 papers). Richard Boehme collaborates with scholars based in United States, United Kingdom and Poland. Richard Boehme's co-authors include Thomas R. Matthews, M A Nowak, Sebastian Bonhoeffer, Hugh McDade, Alison M. Hill, Howard C. Thomas, Roland D. Ciaranello, Ruggero Panebianco, Antonio Bertoletti and A. Cavalli and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Richard Boehme

28 papers receiving 3.3k citations

Hit Papers

Viral dynamics in hepatit... 1996 2026 2006 2016 1996 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Richard Boehme 2.3k 1.6k 721 536 358 28 3.5k
Robert A. Fridell 1.5k 0.7× 1.7k 1.1× 1.1k 1.5× 2.0k 3.7× 644 1.8× 53 4.5k
Andrew W. Tai 613 0.3× 651 0.4× 351 0.5× 1.2k 2.2× 160 0.4× 55 2.6k
Julio Martín‐García 758 0.3× 572 0.4× 761 1.1× 659 1.2× 1.3k 3.6× 53 3.2k
Hengli Tang 1.1k 0.5× 926 0.6× 1.0k 1.4× 1.8k 3.4× 442 1.2× 66 3.9k
Margaret R. MacDonald 999 0.4× 410 0.3× 1.1k 1.5× 1.6k 3.0× 250 0.7× 60 4.0k
David Paul 594 0.3× 650 0.4× 709 1.0× 509 0.9× 224 0.6× 22 2.0k
Felix H. Salazar 828 0.4× 374 0.2× 455 0.6× 1.9k 3.6× 410 1.1× 22 3.0k
Richard J. O. Barnard 578 0.3× 308 0.2× 1.1k 1.6× 994 1.9× 1.1k 3.1× 47 3.1k
Yair Benita 895 0.4× 260 0.2× 703 1.0× 2.3k 4.3× 799 2.2× 21 4.4k
Leopold Kong 671 0.3× 692 0.4× 437 0.6× 1.2k 2.2× 1.2k 3.4× 34 2.9k

Countries citing papers authored by Richard Boehme

Since Specialization
Citations

This map shows the geographic impact of Richard Boehme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Boehme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Boehme more than expected).

Fields of papers citing papers by Richard Boehme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Boehme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Boehme. The network helps show where Richard Boehme may publish in the future.

Co-authorship network of co-authors of Richard Boehme

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Boehme. A scholar is included among the top collaborators of Richard Boehme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Boehme. Richard Boehme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swenson, Luke C., et al.. (2010). Genotypic Determination of Hiv-1 Tropism in the Clinical Setting. Max Planck Institute for Plasma Physics. 4(3). 293–303. 4 indexed citations
2.
Boehme, Richard, et al.. (2009). Key data from the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV. Antiviral Therapy. 14(8). 1195–1208. 4 indexed citations
3.
Lai, Ching‐Lung, Jules L. Dienstag, Eugene R. Schiff, et al.. (2003). Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis B. Clinical Infectious Diseases. 36(6). 687–696. 497 indexed citations
4.
Boni, Carolina, Amalia Penna, Graham S. Ogg, et al.. (2001). Lamivudine Treatment Can Overcome Cytotoxic T–Cell Hyporesponsiveness in Chronic Hepatitis B: New Perspectives for Immune Therapy. Hepatology. 33(4). 963–971. 292 indexed citations
5.
Boni, Carolina, Antonio Bertoletti, Amalia Penna, et al.. (1998). Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.. Journal of Clinical Investigation. 102(5). 968–975. 384 indexed citations
6.
Rizzetto, Mario, P Opolon, Robert Goldin, et al.. (1998). Sustained histologic response is common in the absence of virologic response to interferon (IFN) therapy for chronic hepatitis C (HCV). Gastroenterology. 114. A1291–A1291. 3 indexed citations
7.
Nowak, M A, Sebastian Bonhoeffer, Alison M. Hill, et al.. (1996). Viral dynamics in hepatitis B virus infection.. Proceedings of the National Academy of Sciences. 93(9). 4398–4402. 835 indexed citations breakdown →
9.
Cammack, N., et al.. (1992). Cellular metabolism of (−) enantiomeric 2′-deoxy-3′-thiacytidine. Biochemical Pharmacology. 43(10). 2059–2064. 98 indexed citations
10.
Matthews, Thomas R. & Richard Boehme. (1988). Antiviral Activity and Mechanism of Action of Ganciclovir. Clinical Infectious Diseases. 10(Supplement_3). S490–S494. 293 indexed citations
11.
MCGEE, D. P. C., et al.. (1988). Synthesis and antiviral evaluation of 6'-substituted aristeromycins: potential mechanism-based inhibitors of S-adenosylhomocysteine hydrolase. Journal of Medicinal Chemistry. 31(9). 1798–1804. 50 indexed citations
12.
Boehme, Richard, et al.. (1988). New class of antifungal agents: jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis species. Antimicrobial Agents and Chemotherapy. 32(8). 1154–1157. 78 indexed citations
13.
Boehme, Richard, et al.. (1986). Runway Length as a Determinant of Self-Control in Rats. The Psychological Record. 36(2). 285–288. 5 indexed citations
15.
Smee, Donald F., et al.. (1985). Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses. Antimicrobial Agents and Chemotherapy. 28(2). 240–245. 106 indexed citations
16.
Boehme, Richard, Theodore L. Baker, Ivan N. Mefford, et al.. (1984). Narcolepsy: Cholinergic receptor changes in an animal model. Life Sciences. 34(19). 1825–1828. 57 indexed citations
17.
Mefford, Ivan N., Theodore L. Baker, Richard Boehme, et al.. (1983). Narcolepsy: Biogenic Amine Deficits in an Animal Model. Science. 220(4597). 629–632. 73 indexed citations
18.
Boehme, Richard & Roland D. Ciaranello. (1983). Genetic control of dopamine and serotonin receptors in brain regions of inbred mice. Brain Research. 266(1). 51–65. 36 indexed citations
19.
Ciaranello, Roland D. & Richard Boehme. (1981). Biochemical genetics of neurotransmitter enzymes and receptors: Relationships to schizophrenia and other major psychiatric disorders. Clinical Genetics. 19(5). 358–372. 18 indexed citations
20.
Boehme, Richard & Roland D. Ciaranello. (1981). Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.. Proceedings of the National Academy of Sciences. 78(5). 3255–3259. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026